Startups
珠海横琴爱姆斯坦生物科技有限公司，是一间专注于开发人全能性干细胞（人胚胎干细胞与诱导多能干细胞）治疗产品的生物科技企业。公司产品主要应用于组织修复，神经、心脏、血管、血液系统及治疗自身免疫系统的疾病。我们掌握最先进的干细胞技术，将以始终如一的品质为您提供多种用于治疗及科研的产品。
Overview
Location
United States, Connecticut, Farmington
Mentions in press and media 5
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Sep 2, 2022 | ImStem Biotechnology Appoints CNS and Rare Disease Veteran Rami Levin as its Chief Executive Officer | ImStem Appoints new CEO FARMINGTON, CT, USA, September 2, 2022 /EINPresswire.com/ -- ImStem Biotechnology, a clinical stage biotechnology company focused on stem cell based regenerative cellular therapies to treat serious diseases with high... |
| Sep 1, 2022 | ImStem Biotechnology Appoints CNS and Rare Disease Veteran Rami Levin as its Chief Executive Officer | FARMINGTON, CT, USA, September 1, 2022 /EINPresswire.com/ -- ImStem Biotechnology, Inc., a clinical stage biotechnology company focused on stem cell based regenerative cellular therapies to treat serious diseases with high unmet needs, anno... |
| Jul 20, 2022 | ImStem Biotechnology Appoints Ernst Zwikker, CPA, as Chief Financial Officer | FARMINGTON, CT, USA, July 20, 2022 /EINPresswire.com/ -- ImStem Biotechnology, Inc. (ImStem), a biopharmaceutical company pioneering the development of human embryonic stem cell derived mesenchymal stem cells (hES-MSC) for autoimmune, infla... |
| Jul 5, 2022 | ImStem Files Opening Brief of Appeal to The U.S. Court of Appeals for The Federal Circuit Concerning Stem Cell Patents | inventorship dispute of stem cell patents FARMINGTON, CT, USA, July 5, 2022 /EINPresswire.com/ -- ImStem Biotechnology, Inc. (“ImStem”), a clinical stage company pioneering the development of human embryonic stem cell derived mesenchymal st... |
Reviews 0
FAQ about ImStem Biotechnology, Inc.
What has the press written about ImStem Biotechnology, Inc.?
Parsers VC has collected 5 articles mentioning ImStem Biotechnology, Inc., among them “ImStem Biotechnology Appoints CNS and Rare Disease Veteran Rami Levin as its Chief Executive Officer” (Sep 2, 2022) and “ImStem Biotechnology Appoints CNS and Rare Disease Veteran Rami Levin as its Chief Executive Officer” (Sep 1, 2022).
Is ImStem Biotechnology, Inc. still active?
Yes, ImStem Biotechnology, Inc. is active; its latest activity on Parsers VC dates from Sep 6, 2022.